Results

Total Results: 1,313 records

Showing results for "size".

21. Infantile-Hemangioma Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
    January 01, 2016 - most children, IH will become apparent in the first few weeks of life and reach 80 percent of total size … Specific disease characteristics, such as lesion size, location, rate of growth, and persistence as … Lesion characteristics such as size, location, and type (e.g., superficial, deep) also influence the … Studies comparing propranolol and steroids to reduce IH size had conflicting findings. … Low SOE for effectiveness of PDL vs. observation in reducing lesion size. PDL vs.

22. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
    January 01, 2024 - Definitions of effect sizes Effect Size Definition No effect/trivial effect • Below thresholds for … placebo in the short term (4 weeks to <6 months) Product, THC to CBD Ratio Pain Responsea Effect Size … (N Studies) [SOE] Pain Severity Effect Size (N Studies) [SOE] Function Effect Size (N Studies … (N Studies) [SOE] SAE Effect Size (N Studies) [SOE] Dizziness Effect Size (N Studies) [SOE … ] Nausea Effect Size (N Studies) [SOE] Sedation Effect Size (N Studies) [SOE] Comparable

23. Template for Draft Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
    October 06, 2006 - at randomization CABG sample size at randomization Group 1 outcome 1 Specify: Specify … at randomization CABG sample size at randomization Group 2 outcome 1 Specify: Specify … at randomization CABG sample size at randomization Group 3 outcome 1 Specify: Specify … at randomization CABG sample size at randomization Group 4 outcome 1 Specify: Specify … at randomization CABG sample size at randomization Group 1 outcome 2 Specify: Specify

24. Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
    January 01, 2022 - Definitions of effect sizes Effect Size Definition Small effect • MD 0.5 to 1.0 points on a 0 to 10 … placebo in the short term (4 weeks to <6 months) Product, THC to CBD Ratio Pain Response Effect Size … (N Studies) [SOE] Pain Severity Effect Size (N Studies) [SOE] Function Effect Size (N Studies … (N Studies) [SOE] SAE Effect Size (N Studies) [SOE] Dizziness Effect Size (N Studies) [SOE … ] Nausea Effect Size (N Studies) [SOE] Sedation Effect Size (N Studies) [SOE] Comparable

25. White Paper: Living Systematic Reviews: Practical Considerations for Adapting Scope and Communicating the Evolving Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
    June 01, 2025 - were available but there was no change to findings (i.e., strength of evidence assessment or effect size … The TEP also emphasized the importance of highlighting changes in effect size or strength of evidence … (N Studies) [SOE] Pain Severity Effect Size (N Studies) [SOE] Function Effect Size (N Studies … (N Studies) [SOE] SAE Effect Size (N Studies) [SOE] Dizziness Effect Size (N Studies) [SOE … ] Nausea Effect Size (N Studies) [SOE] Sedation Effect Size (N Studies) [SOE] Comparable

26. Evaluation of Dietary Protein Intake Requirements (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
    November 28, 2023 - screening, we will “tag” studies in PICO portal (using certain identifiers, such as small sample size … direct link between intervention and outcome); 3) consistency (similarity of effect direction and size … Population, Intervention, Comparator, Outcome, Timing, Setting/Study Design (PICOTS) Study Size … Thus, studies performed in this population will also be included regardless of sample size. 11/ … Thus, studies performed in this population will also be included regardless of sample size. 11/

27. White Paper: Enhancing Systematic Review Methods by Incorporating Unpublished Drug Trials (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/unpublished-drug-trials-white-paper.pdf
    December 01, 2024 - paroxetine for PTSD treatment FDA Study ID Corresponding Publication Regulatory Decision Sample Size … The figures also illustrate differences in the lower confidence limit of the overall effect size: -7.02 … Effect Size Considerations: The likelihood of unpublished negative trials and the likelihood that unpublished … Anticipated effect size Drugs with low or small effect sizes Drug with high or large effect sizes … Evidence size Few large trials published There are multiple large good-quality trials.

28. Continuous-Outcomes-Quantitative-Synthesis Methods (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
    March 01, 2011 - Look up the sample size on Table 1 and use the given divisor. … For example, if the sample size is 22, then SD could be estimated as range/3.819. … a sample size of 30 with a SD of 7.53 for the mean difference. … Baseline distribution and conditional size. J Biopharm Stat. 1993 Sep;3(2):265-76. … Estimation of effect size from a series of independent experiments.

29. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
    July 01, 2017 - over another, patient factors (e.g., comorbidities, life expectancy), tumor characteristics (e.g., size … for regional or distant metastases (���), some other associations were observed: �– Increased tumor size … 12 (9,401) A positive relationship between tumor size and malignancy risk was found. 1.326 (1.220 … per tumor size in centimeters. … c The odds ratio represents the effect size per age in years.

30. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
    April 01, 2020 - Definitions of effect sizes Effect Size Definition Small effect • MD 0.5 to 1.0 points on a 0 to 10 … SOE Function Short Term Effect Size SOE QoL Short Term Effect Size SOE Neuropathic pain Pregabalin … SOE SNRIs (duloxetine/ milnacipran) Intermediate Term Effect Size SOE TCAs Short Term Effect Size … SOE NSAID Intermediate Term Effect Size SOE NSAID Long Term Effect Size SOE Topical Diclofenac … Effect Size SOE nsNSAID Versus Celecoxib Long Term Effect Size SOE WAE Small ++ None +

31. Executive Summary_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2024 Update of the Evidence Base for the PTSD Trials Standardized Data Repository (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-final-report-update-2024-executive-summ.pdf
    January 01, 2024 - newly added studies had sample sizes ranging from 22 to 1,001, with most studies (61%) having a sample size

32. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - of 243 patients51 while a smaller observational study reported no cases.19 Despite the large effect size … bias table Author, Year Related Studies Trial ID Location Setting Study Design Study Size … 2024 C-2 Author, Year Related Studies Trial ID Location Setting Study Design Study Size … 2024 C-3 Author, Year Related Studies Trial ID Location Setting Study Design Study Size … 2024 C-4 Author, Year Related Studies Trial ID Location Setting Study Design Study Size

33. Study Eligibility Criteria (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/study-eligibility-criteria.ppt
    January 01, 2000 - depression risk) Country (United States only) Setting (hospital-based studies only) Study population size … Using Narrow Criteria Can be helpful in culling homogenous literature Can reduce size of the literature … size N ≥ 50 in each study at study start. … A total of 79 studies out of more than 2,000 were excluded on the basis of study size. … This decision was based on expert opinion and the size and scope of the literature.

34. White Paper: Narratively Describing Effects of Interventions in Systematic Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-roadmap-interventions.pdf
    November 01, 2020 - . • Five constructs (direction of effect, size of effect, clinical importance, statistical significance … These two items were certainty of evidence and size of effect. … For example, the size of an effect can affect the judgment about clinical importance. … Clinical importance and size of effect may affect the determination of the direction of effect (e.g. … Judgments about the clinical importance and size constructs are needed to determine the precision and

35. Appendixes A-D: Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendices.pdf
    January 01, 2025 - surveillance (CT scan, renal ultrasound, abdominal radiograph) to detect radiographic stone recurrence, size … stone*”[tw] OR “cystine calcul*”[tw] OR “struvite stone*”[tw] OR “struvite calcul*”[tw] OR “stone size … (less than 30 per arm) Ala-Opas, 19875 Excluded for ineligible sample size (less than 30 per arm) … Barcelo, 19936 Excluded for ineligible sample size (less than 30 per arm) Borghi, 19937 Excluded for … for ineligible sample size (less than 30 per arm) Scholz, 198228 Excluded for ineligible sample size

36. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
    May 01, 2012 - See the following section regarding sample size estimates. … See Table 3 in sample size section. … • Resource use, size, and duration o This design option would require a sample size of at least … Sample size required to detect treatment effects in a 2x2 factorial design Effect Effect size Approximate … required to detect a treatment effect of a given size.

37. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
    June 01, 2016 - affected children, IH becomes apparent in the first few weeks of life and reaches 80 percent of total size … Conclusions Propranolol is effective at reducing IH lesion size (i.e., lesion clearance) when compared … Findings were limited by study size, lack of standard processes, and lack of direct comparison at the … of Treatment Interventions for Infantile Hemangioma Intervention Outcome Studies Finding Effect Size … Findings were limited by study size, lack of standard processes, and lack of direct comparison at the

38. Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
    August 22, 2012 - risk factors for DCIS progression and recurrence include com- edo histology, younger age, larger tumor size … Tumor size: We defined tumor size using the SEER collaborative staging tumor extension field. … Women with DCIS also had a higher incidence of un- known tumor size and grade (Table 1). … Likewise, the association between tumor size and ER/PR testing dif- fered between DCIS and invasive … In women with invasive cancer, rates of ER/PR testing were relatively stable across tumor size.

39. CER 226: Evidence summary_Labor Dystocia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_2.pdf
    May 01, 2020 - We also did not include interventions such as estimation of fetal size or clinical pelvimetry which … use: Evidence summary for major outcomes and adverse events Category Outcome Study Design (Sample Size … control: Evidence summary in women with unspecified parity Category Outcome Study Design (Sample Size … Moderate (Imprecise) 11 Category Outcome Study Design (Sample Size) Conclusion SOE (Rationale … control: Evidence summary in women with unspecified parity Category Outcome Study Design (Sample Size

40. Executive Summary_Comparative Effectiveness Review No. 271: Nonpharmacologic Treatments for Maternal Mental Health Conditions (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-executive-summary.pdf
    July 01, 2024 - treatments for depressive or anxiety disorders Intervention Population Outcome Conclusion Effect Size … (95% CI) Effect Size, Back- Transformed (95% CI) SoE CBT vs. … 1.62, 0.06) Insufficient evidence 5 Intervention Population Outcome Conclusion Effect Size … (95% CI) Effect Size, Back- Transformed (95% CI) SoE CBT vs.